ArticleACS omega2023
Chemically Functionalized Gold Nanosphere-Blended Nematic Liquid Crystals for Photonic Applications.
Article in ACS omega, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A demand for functional materials that are capable of tailoring light-emissive properties has apparently been rising nowadays substantially for their utilization in organic optoelectronic devices. Motivated by such promising characteristics, we present highly emissive as well as aggregation-induced emission (AIE) electroluminescent composite systems composed of a nematic liquid crystals (NLC) blended with polyethylene-functionalized gold nanospheres (GNSs). The major findings of this study include superior electro-optical properties such as threshold voltage reduction by around 24%. The fall time is reduced by 11.50, 30.33, 49.33, and 63.17% respectively, and rotational viscosity is reduced by 13.86, 32.77, 36.97, and 49.58% for 5.0 × 10
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.